RecruitingAcute Kidney Injury
Ultra-Low Contrast Angiography in AKI
Eligible age
18–100 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.
Sponsor: Tulane University
You may qualify if…
- ✓ Hospitalized patients who have AKI at admission or who develop AKI during admission and require invasive coronary angiography will be included in the trial.
You may not qualify if…
- ✕ Stabilized renal function manifested by unchanged or downtrending serum creatinine during a 24-hour period prior to enrollment.
- ✕ Contraindication for invasive coronary angiography other than AKI.
- ✕ Percutaneous coronary intervention is indicated and cannot be postponed by 7 days.
- ✕ Need for renal replacement therapy before coronary angiography or planned renal replacement therapy after coronary angiography (if premeditated before coronary angiography).
- ✕ Administration of intravascular contrast media during 7 days prior to the coronary angiography or within 6 days after coronary angiography.
- ✕ Pregnant patients, prisoners, cognitively impaired subjects, age below 18 years, unable or unwilling to provide informed consent.
Where it's recruiting
Louisiana
New Orleans
Source: ClinicalTrials.gov · NCT05906758 · last updated 2026-05-18